Motion to Intervene Re: 340B Contract Pharmacy

UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF INDIANA
INDIANAPOLIS DIVISION


ELI LILLY AND COMPANY,
Lilly Corporate Center
893 Delaware Street
Indianapolis IN 46225, et al.,

Plaintiffs,

–v–                                                            Case No. 1:21-cv-81-SEB-MJD

NORRIS COCHRAN
200 Independence Avenue, SW
Washington, DC 20201, et al.,

Defendants.

 

THE AMERICAN HOSPITAL ASSOCIATION, 340B HEALTH, AMERICA’S ESSENTIAL HOSPITALS, THE ASSOCIATION OF AMERICAN MEDICAL COLLEGES, THE CHILDREN’S HOSPITAL ASSOCIATION, AND THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACIST’S MOTION TO INTERVENE

The American Hospital Association, 340B Health, America’s Essential Hospitals, the Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a the Children’s Hospital Association, and American Society of Health-System Pharmacists (collectively the Proposed Intervenors) move this Court, pursuant to Federal Rule of Civil Procedure 24(a), or in the alternative pursuant to Federal Rule of Civil Procedure 24(b), to Intervene as Defendants in this lawsuit.

In support of this motion, Proposed Intervenors submit a Memorandum in Support of the Motion to Intervene. Proposed Intervenors also submit a Proposed Order. Exhibit A (the Declaration of Maureen Testoni) and Exhibit B (Intervenors Proposed Answer) are attached to this Motion.

Related Resources

Special Bulletin
Public
At A Glance The Health Resources and Services Administration (HRSA) Dec. 10 released its long-awaited final rule implementing an Affordable Care Act (ACA)…
Special Bulletin
Public
At A Glance The Centers for Medicare & Medicaid Services (CMS) yesterday released the calendar year (CY) 2021 outpatient prospective payment system (…
Special Bulletin
Public
The Centers for Medicare & Medicaid Services (CMS) Nov. 20 released an interim final rule implementing the Most Favored Nation (MFN) Model, a new payment…
Letter/Comment
Public
The AHA on Friday sent a letter to the Health Resources and Services Administration’s Office of Pharmacy Affairs urging the agency to order drug manufacturers…
Letter/Comment
Public
In a letter to Senator Lamar Alexander and Representative Greg Walden, AHA expresses strong support for the 340B Drug Pricing Program.
Action Alert
Member
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Department of Health and Human Services Secretary…